RB
Regina E.M. Baiden-Amissah
KU Leuven, University of Cape Coast, University of Porto
0000-0003-3071-7726
Employment
-
KU Leuven PhD Researcher2019 - Present
-
University of Cape Coast Lecturer2016 - 2018
Education
-
KU Leuven PhD in Biomedical Sciences2019 - Present
-
University of Porto MSc. Molecular Oncology2011 - 2013
-
University of Cape Coast Bachelor of Science2004 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial Save
- Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial Save
- PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade Save
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study (vol 72, pg 475, 2022) Save
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study Save
- Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers Save
- Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making? Save
- Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity Save